Expression of the angiogenesis markers endocan in Cushing’s syndrome due to cortisol producing adenoma
- 9 November 2022
- journal article
- research article
- Published by Springer Nature in Endocrine
- Vol. 79 (3) , 554-558
Abstract
Purpose In this study, we aimed to investigate the endocan expression in tissue samples of patients diagnosed with Cushing’s syndrome (CS) due to Cortisol-Producing-Adenoma (CPA) and compare it with normal adrenal cortex tissue, and also to evaluate the correlations of endocan expression with clinical and histopathological features. Methods 11 patients who were operated for CS due to CPA between 2009–2021 and 14 control subjects with normal adrenal cortex were included in the study. Demographic, laboratory and clinicopathological data of the patients were recorded. Sections of 4–5 µm thickness were taken from paraffin blocks of patients diagnosed with CS due to CPA and control subjects with normal adrenal cortex tissue. The sections were then stained in a closed system automatic immunohistochemical staining device to perform immunohistochemical analysis. The endocan positive grade were determined based on the proportion of stained cells on a scale of negative to strong. Results The number of subjects with positive endocan expression and the mean endocan expression level in the CS group were significantly higher than the control group (p = 0.005, p < 0.001, respectively). No correlation was found between endocan expression and clinical and histopathological features. Conclusion According to the results of our study, endocan overexpression in CPA tissues may be related to the hormonal functionality of CPA.Keywords
All Related Versions
This publication has 12 references indexed in Scilit:
- Prognostic value of endocan expression in cancers: evidence from meta-analysisOncoTargets and Therapy, 2016
- A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasionPituitary, 2016
- Endocan, a new invasion and angiogenesis marker of pituitary adenomasJournal of Neuro-Oncology, 2014
- Molecular Mediators of AngiogenesisJournal of Burn Care & Research, 2010
- Vascular endocan (ESM‐1) is markedly overexpressed in clear cell renal cell carcinomaHistopathology, 2009
- Endocan Expression and Relationship with Survival in Human Non–Small Cell Lung CancerClinical Cancer Research, 2006
- Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1The Journal of Clinical Endocrinology & Metabolism, 2001
- HIF-1 and human disease: one highly involved factorGenes & Development, 2000
- Vascularity in human adrenal cortex.1998
- Morbidity and mortality in Cushing's disease: an epidemiological approachClinical Endocrinology, 1994